Section I
1 – 10 of 4743
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases
(
- Contribution to journal › Article
-
Mark
Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment : a post-hoc analysis of the randomised, phase 3 SENOMAC trial
(
- Contribution to journal › Article
-
Mark
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial
(
- Contribution to journal › Article
-
Mark
Effects of Recombinant α1-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to 177Lu-Octreotate
(
- Contribution to journal › Article
-
Mark
Molecular Subtypes Are Associated With Clinical Benefit in Cisplatin-Treated Metastatic Urothelial Cancer Patients
(
- Contribution to journal › Article
-
Mark
Infections in patients with mantle cell lymphoma
(
- Contribution to journal › Article
-
Mark
Safe to save blood in ovarian cancer surgery : time to change transfusion habits
(
- Contribution to journal › Article
-
Mark
Regulation of estrogen receptor alpha by promoter methylation, alternative splicing and microRNA
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma : a 10-year follow-up
(
- Contribution to journal › Letter
-
Mark
The National Swedish Lymphoma Register – a systematic validation of data quality
(
- Contribution to journal › Article